Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Surmodics Inc has a consensus price target of $43 based on the ratings of 4 analysts. The high is $43 issued by Lake Street on March 7, 2025. The low is $43 issued by Lake Street on March 7, 2025. The 3 most-recent analyst ratings were released by Lake Street, Lake Street, and Sidoti & Co. on March 7, 2025, May 29, 2024, and May 29, 2024, respectively. With an average price target of $43 between Lake Street, Lake Street, and Sidoti & Co., there's an implied 39.84% upside for Surmodics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/07/2025 | Buy Now | 39.84% | Lake Street | Brooks O'Neil36% | $43 → $43 | Upgrade | Hold → Buy | Get Alert |
01/30/2025 | Buy Now | — | Needham | Mike Matson57% | — | Reiterates | Hold → Hold | Get Alert |
11/07/2024 | Buy Now | — | Needham | Mike Matson57% | — | Reiterates | → Hold | Get Alert |
08/05/2024 | Buy Now | — | Needham | Mike Matson57% | — | Reiterates | → Hold | Get Alert |
05/30/2024 | Buy Now | — | Barrington Research | Michael Petusky52% | — | Downgrade | Outperform → Market Perform | Get Alert |
05/29/2024 | Buy Now | 39.84% | Lake Street | Brooks O'Neil36% | → $43 | Downgrade | Buy → Hold | Get Alert |
05/29/2024 | Buy Now | 39.84% | Sidoti & Co. | James Sidoti65% | → $43 | Downgrade | Buy → Neutral | Get Alert |
05/29/2024 | Buy Now | — | Needham | Mike Matson57% | — | Downgrade | Buy → Hold | Get Alert |
05/02/2024 | Buy Now | 130.89% | Barrington Research | Michael Petusky52% | $71 → $71 | Maintains | Outperform | Get Alert |
05/01/2024 | Buy Now | 39.84% | Needham | Mike Matson57% | $47 → $43 | Maintains | Buy | Get Alert |
04/10/2024 | Buy Now | 52.85% | Needham | Mike Matson57% | $47 → $47 | Reiterates | Buy → Buy | Get Alert |
02/01/2024 | Buy Now | 52.85% | Needham | Mike Matson57% | $44 → $47 | Maintains | Buy | Get Alert |
11/09/2023 | Buy Now | 130.89% | Barrington Research | Michael Petusky52% | $69 → $71 | Maintains | Outperform | Get Alert |
11/08/2023 | Buy Now | 43.09% | Needham | Mike Matson57% | $50 → $44 | Maintains | Buy | Get Alert |
08/02/2023 | Buy Now | 62.6% | Needham | Mike Matson57% | $36 → $50 | Reiterates | Buy → Buy | Get Alert |
06/21/2023 | Buy Now | 124.39% | Barrington Research | Michael Petusky52% | $60 → $69 | Maintains | Outperform | Get Alert |
06/20/2023 | Buy Now | 17.07% | Needham | Mike Matson57% | → $36 | Reiterates | Buy → Buy | Get Alert |
06/13/2023 | Buy Now | 17.07% | Needham | Mike Matson57% | → $36 | Upgrade | Hold → Buy | Get Alert |
02/13/2023 | Buy Now | — | Needham | Mike Matson57% | — | Downgrade | Buy → Hold | Get Alert |
02/07/2023 | Buy Now | 95.12% | Barrington Research | Michael Petusky52% | $61 → $60 | Maintains | Outperform | Get Alert |
02/07/2023 | Buy Now | 10.57% | Needham | Mike Matson57% | $46 → $34 | Maintains | Buy | Get Alert |
01/20/2023 | Buy Now | 98.37% | Barrington Research | Michael Petusky52% | $70 → $61 | Maintains | Outperform | Get Alert |
04/28/2022 | Buy Now | 49.59% | Needham | Mike Matson57% | $58 → $46 | Maintains | Buy | Get Alert |
The latest price target for Surmodics (NASDAQ:SRDX) was reported by Lake Street on March 7, 2025. The analyst firm set a price target for $43.00 expecting SRDX to rise to within 12 months (a possible 39.84% upside). 11 analyst firms have reported ratings in the last year.
The latest analyst rating for Surmodics (NASDAQ:SRDX) was provided by Lake Street, and Surmodics upgraded their buy rating.
The last upgrade for Surmodics Inc happened on March 7, 2025 when Lake Street raised their price target to $43. Lake Street previously had a hold for Surmodics Inc.
The last downgrade for Surmodics Inc happened on May 30, 2024 when Barrington Research changed their price target from N/A to N/A for Surmodics Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Surmodics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Surmodics was filed on March 7, 2025 so you should expect the next rating to be made available sometime around March 7, 2026.
While ratings are subjective and will change, the latest Surmodics (SRDX) rating was a upgraded with a price target of $43.00 to $43.00. The current price Surmodics (SRDX) is trading at is $30.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.